Loading clinical trials...
Loading clinical trials...
A Phase 2 Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy
Conditions
Interventions
Biopsy Procedure
Biospecimen Collection
+2 more
Locations
5
United States
Cedars Sinai Medical Center
Los Angeles, California, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Duke University Medical Center
Durham, North Carolina, United States
University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Start Date
September 12, 2024
Primary Completion Date
November 1, 2026
Completion Date
May 1, 2027
Last Updated
April 13, 2026
NCT07219147
NCT06325046
NCT06831032
NCT05691465
NCT06173362
NCT06205316
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions